Okami, S.; Ohlmeier, C.; Takeichi, M.; Aguila, M.; Holl, K.; Michel, A.; Lecomte, C.; Ide, T.
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan. J. Clin. Med. 2024, 13, 3222.
https://doi.org/10.3390/jcm13113222
AMA Style
Okami S, Ohlmeier C, Takeichi M, Aguila M, Holl K, Michel A, Lecomte C, Ide T.
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan. Journal of Clinical Medicine. 2024; 13(11):3222.
https://doi.org/10.3390/jcm13113222
Chicago/Turabian Style
Okami, Suguru, Christoph Ohlmeier, Makiko Takeichi, Mireia Aguila, Katsiaryna Holl, Alexander Michel, Coralie Lecomte, and Tomomi Ide.
2024. "Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan" Journal of Clinical Medicine 13, no. 11: 3222.
https://doi.org/10.3390/jcm13113222
APA Style
Okami, S., Ohlmeier, C., Takeichi, M., Aguila, M., Holl, K., Michel, A., Lecomte, C., & Ide, T.
(2024). Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan. Journal of Clinical Medicine, 13(11), 3222.
https://doi.org/10.3390/jcm13113222
